These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 40548)

  • 21. Human islets in mixed islet grafts protect mouse pancreatic beta-cells from alloxan toxicity.
    Tyrberg B; Eizirik DL; Marklund SL; Olejnicka B; Madsen OD; Andersson A
    Pharmacol Toxicol; 1999 Dec; 85(6):269-75. PubMed ID: 10628902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superoxide dismutase-inhibitible reduction of cytochrome c by the alloxan radical. Implications for alloxan cytotoxicity.
    Winterbourn CC
    Biochem J; 1982 Dec; 207(3):609-12. PubMed ID: 6299273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective role of superoxide dismutase against diabetogenic drugs.
    Gandy SE; Buse MG; Crouch RK
    J Clin Invest; 1982 Sep; 70(3):650-8. PubMed ID: 6213639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells.
    Wilson GL; Patton NJ; McCord JM; Mullins DW; Mossman BT
    Diabetologia; 1984 Dec; 27(6):587-91. PubMed ID: 6241574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of alloxan on islet tissue permeability: protection and reversal by NADPH.
    Cooperstein SJ; Watkins D
    Biochem Biophys Res Commun; 1977 Dec; 79(3):756-62. PubMed ID: 23119
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of alloxan on the islets of Langerhans. Possible mechanisms of diabetogenic action.
    Borg LA
    Acta Biol Med Ger; 1981; 40(1):71-6. PubMed ID: 7020307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The protective role of copper-zinc superoxide dismutase against alloxan-induced diabetes: morphological aspects.
    Thaete LG; Crouch RK; Buse MG; Spicer SS
    Diabetologia; 1985 Sep; 28(9):677-82. PubMed ID: 3905479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotinamide does not protect islet B-cell metabolism against alloxan toxicity.
    Sandler S; Welsh M; Andersson A
    Diabetes; 1984 Oct; 33(10):937-43. PubMed ID: 6237009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptozotocin-induced impairment of islet B-cell metabolism and its prevention by a hydroxyl radical scavenger and inhibitors of poly(ADP-ribose) synthetase.
    Sandler S; Welsh M; Andersson A
    Acta Pharmacol Toxicol (Copenh); 1983 Nov; 53(5):392-400. PubMed ID: 6318515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alloxan acts as a prooxidant only under reducing conditions: influence of melatonin.
    Brömme HJ; Ebelt H; Peschke D; Peschke E
    Cell Mol Life Sci; 1999 Mar; 55(3):487-93. PubMed ID: 10228562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro.
    Jörns A; Munday R; Tiedge M; Lenzen S
    J Endocrinol; 1997 Nov; 155(2):283-93. PubMed ID: 9415063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutathione-mediated redox cycling of alloxan. Mechanisms of superoxide dismutase inhibition and of metal-catalyzed OH. formation.
    Winterbourn CC; Munday R
    Biochem Pharmacol; 1989 Jan; 38(2):271-7. PubMed ID: 2536542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of cyclic AMP and alloxan on insulin secretion in isolated rat islets perifused in vitro.
    Tomita T; Scarpelli DG
    Endocrinology; 1977 May; 100(5):1327-33. PubMed ID: 191240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects in vitro of alloxan on the glucose metabolism of mouse pancreatic B-cells.
    Borg LA; Eide SJ; Andersson A; Hellerström C
    Biochem J; 1979 Sep; 182(3):797-802. PubMed ID: 391224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement of a diperoxovanadate-derived intermediate for the interdependent oxidation of vanadyl and NADH.
    Ravishankar HN; Ramasarma T
    Arch Biochem Biophys; 1995 Jan; 316(1):319-26. PubMed ID: 7840632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-enzymatic reduction of alloxan by reduced nicotinamide nucleotide.
    Miwa I; Okuda J
    Biochem Pharmacol; 1982 Mar; 31(6):921-5. PubMed ID: 7082373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment.
    Kukiełka E; Dicker E; Cederbaum AI
    Arch Biochem Biophys; 1994 Mar; 309(2):377-86. PubMed ID: 8135551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced alloxan-induced beta-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular-superoxide dismutase.
    Sentman ML; Jonsson LM; Marklund SL
    Free Radic Biol Med; 1999 Oct; 27(7-8):790-6. PubMed ID: 10515583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus.
    Welsh N; Margulis B; Borg LA; Wiklund HJ; Saldeen J; Flodström M; Mello MA; Andersson A; Pipeleers DG; Hellerström C
    Mol Med; 1995 Nov; 1(7):806-20. PubMed ID: 8612203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation.
    Henderson BW; Miller AC
    Radiat Res; 1986 Nov; 108(2):196-205. PubMed ID: 3097749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.